From Monocytes to M1/M2 Macrophages: Phenotypical vs. Functional Differentiation
Open accessAbstract
Studies on monocyte and macrophage biology and differentiation have revealed the pleiotropic activities of these cells. Macrophages are tissue sentinels that maintain tissue integrity by eliminating/repairing damaged cells and matrices. In this M2-like mode, they can also promote tumor growth. Conversely, M1-like macrophages are key effector cells for the elimination of pathogens, virally infected, and cancer cells. Macrophage differentiation from monocytes occurs in the tissue in concomitance with the acquisition of a functional phenotype that depends on microenvironmental signals, thereby accounting for the many and apparently opposed macrophage functions. Many questions arise. When monocytes differentiate into macrophages in a tissue (concomitantly adopting a specific functional program, M1 or M2), do they all die during the inflammatory reaction, or do some of them survive? Do those that survive become quiescent tissue macrophages, able to react as naïve cells to a new challenge? Or, do monocyte-derived tissue macrophages conserve a "memory" of their past inflammatory activation? This review will address some of these important questions under the general framework of the role of monocytes and macrophages in the initiation, development, resolution, and chronicization of inflammation.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Macrophages in granuloma highly express M2-specific markers CD163 and MHC II.
“macrophages in granuloma highly expressed M2-specific markers, such as CD163 and MHC II [50].”
From Asbestos conceives Fe(II)-dependent mutagenic stromal milieu through ceaseless macrophage ferroptosis and β-catenin induction in mesothelium (2020) · cites this paper as [50]
The Monocyte development and heterogeneity section (Table 1; page unavailable) lists CD163 and MHC class II on some blood monocyte subsets, but does not identify them as M2-specific markers. The passages on macrophage phenotypes do not report their expression in granulomas; searches for granuloma, CD163, and MHC class II found no passage supporting that observation. (LLM, conf=0.70)
Experimental — accuracy not yet measuredIndividual macrophages can dynamically switch phenotype, altering their functional properties.
“Moreover, individual macrophages hold the potential for a dynamic phenotype switch, which affects the functional properties ofthe macrophage155,156.”
From Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities (2019) · cites this paper as [156]
Microglia are classified into M1 (classically activated) cells that secrete proinflammatory cytokines and M2 (alternatively activated) cells that promote tissue regeneration and repair.
“Microglia are classified into two subtypes: classically activated (M1) cells, which secrete proinflammatory cytokines, and alternatively activated (M2) cells, which promote tissue regeneration and repair [9–12].”
From Neuron secrete exosomes containing miR-9-5p to promote polarization of M1 microglia in depression (2022) · cites this paper as [12]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
The citation lists haven’t been fetched yet
References 227 · Cited by 2,067
- Authors
- Italiani, P., & Boraschi, D.
- Affiliations
- Institute of Protein Biochemistry (IT)
- Corresponding author
- Italiani, Paola
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2014-10-17
- Volume
- 5
- Pages
- 514-514
- ISSN
- 1664-3224 (ISSN-L)
- PMC
- PMC4201108
- OpenAlex
- W2089573422
- Cited by
- 2,067
- References
- 227
- Citations by year
- 2026: 133 · 2025: 180 · 2024: 234 · 2023: 219 · 2022: 232 · 2021: 231 · 2020: 232 · 2019: 148 · 2018: 166 · 2017: 142 · 2016: 97 · 2015: 50 · 2014: 1
- FWCI
- 9.44
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Frontiers in Immunology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- European Commission (316383)
- Fondazione Cariplo (2011-2114)
- FP7 People: Marie-Curie Actions
- FP7 Health (602461, FP7-HEALTH-2013-INNOVATION)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
- Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
- Keywords
- monocytes, macrophage differentiation, M1 macrophages, M2 macrophages, tissue macrophages, inflammation resolution, chronic inflammation, tumor-associated macrophages, monocyte-derived macrophages
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review